Invalid Symbol

Stock Research for ATNM

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


ATNM Stock Chart & Research Data

The ATNM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATNM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ATNM Due diligence Resources & Stock Charts

The ATNM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ATNM Detailed Price Forecast - CNN Money CNN View ATNM Detailed Summary - Google Finance
Yahoo View ATNM Detailed Summary - Yahoo! Finance Zacks View ATNM Stock Research & Analysis -

Stock Analysis

TradeIdeas View ATNM Trends & Analysis - Trade-Ideas Barrons View ATNM Major Holders - Barrons
NASDAQ View ATNM Call Transcripts - NASDAQ Seeking View ATNM Breaking News & Analysis - Seeking Alpha
Spotlight View ATNM Annual Report - OTC Report View ATNM OTC Short Report -
TradeKing View ATNM Fundamentals - TradeKing Charts View ATNM SEC Filings - Bar Chart
WSJ View Historical Prices for ATNM - The WSJ Morningstar View Performance/Total Return for ATNM - Morningstar
MarketWatch View the Analyst Estimates for ATNM - MarketWatch CNBC View the Earnings History for ATNM - CNBC
StockMarketWatch View the ATNM Earnings - StockMarketWatch MacroAxis View ATNM Buy or Sell Recommendations - MacroAxis
Bullish View the ATNM Bullish Patterns - American Bulls Short Pains View ATNM Short Pain Metrics -

Social Media Mentions

StockTwits View ATNM Stock Mentions - StockTwits PennyStocks View ATNM Stock Mentions - PennyStockTweets
Twitter View ATNM Stock Mentions - Twitter Invest Hub View ATNM Investment Forum News - Investor Hub
Yahoo View ATNM Stock Mentions - Yahoo! Message Board Seeking Alpha View ATNM Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ATNM - Insider Cow View Insider Transactions for ATNM - Insider Cow
CNBC View ATNM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ATNM - OTC Markets
Yahoo View Insider Transactions for ATNM - Yahoo! Finance NASDAQ View Institutional Holdings for ATNM - NASDAQ

Stock Charts

FinViz View ATNM Stock Insight & Charts - StockCharts View ATNM Investment Charts -
BarChart View ATNM Stock Overview & Charts - BarChart Trading View View ATNM User Generated Charts - Trading View

Latest Financial News for ATNM

Actinium Pharmaceuticals Announces Product Showcase and Other Visibility Extending Activities at the BMT Tandem Meetings, the Combined Annual Meetings of the Two Leading Transplant Organizations
Posted on Tuesday February 20, 2018

Actimab-MDS to be featured in a Product Theater on February 21 st Members of Actinium’ s executive and clinical development teams to participate in conference activities and extend the visibility of the ...

Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AML
Posted on Monday February 12, 2018

•Conference call to be held on Tuesday, February 13 th, 2018 at 4:30 PM ET to discuss planned Phase 1 clinical trial with Dr. •New trial represents expansion of Actinium’ s CD33 program and increases addressable ...

Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
Posted on Monday February 12, 2018

•To be a shareholder of record, investors are advised to own Actinium stock by 4:00 PM ET, Monday, February 12, 2018 to account for T +2 settlement timing. •Actinium’ s executive management and directors ...

Actinium Appoints Anil Kapur as Chief Commercial Officer to Build Critical Commercial & Launch Capabilities Focused on Myeloablation
Posted on Thursday February 08, 2018

Kapur joins Actinium with more than two decades of biopharmaceutical commercial experience at Johnson & Johnson, BAXALTA and Bristol-Myers Squibb. -Global leader with deep expertise in Oncology Marketing ...

Actinium Pharmaceuticals Announces Product Showcase and Other Visibility ...
GlobeNewswire (press release) - 1 hour ago
NEW YORK, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that representatives from the Company's executive and clinical development teams will be attending the BMT ...

Actinium Pharmaceuticals Appoints Dr. Dale L. Ludwig, Ph.D. as Chief ...
GlobeNewswire (press release) - Jan 8, 2018
NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company"), announced today that Dr.

Actinium Pharmaceuticals Announces Rights Offering
GlobeNewswire (press release) - Feb 1, 2018
Under the proposed rights offering, Actinium would distribute non-transferable subscription rights to purchase 35,714,285 units at a subscription price per unit of $0.70, to its stockholders and certain participating warrant holders on the record date ...
What The Investing World Hopes From Actinium Pharmaceuticals, Inc. (ATNM ... - Post Analyst

Actinium Pharmaceuticals to Present at Biotech Showcase™ 2018 and Participate ...
GlobeNewswire (press release) - Jan 3, 2018
NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or "the Company") announced today that the Company will be attending the Biotech Showcase™ 2018 being held January 8-10, 2018 at the Hilton ...

Enter a stock symbol to view the stock details.